Cargando…
The Futility of Futility Analyses in Adjuvant Trials in Hormone Receptor–Positive Breast Cancer
An interim analysis is commonly used in phase III superiority trials to compare treatment arms, with the goal of terminating exposure of patients to ineffective or unsafe drugs or to identify highly effective therapies for earlier public disclosure. Traditionally, interim analyses have been designed...
Autores principales: | Lohmann, Ana Elisa, Ennis, Marguerite, Parulekar, Wendy R, Chen, Bingshu E, Tomlinson, George, Goodwin, Pamela J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275774/ https://www.ncbi.nlm.nih.gov/pubmed/35377437 http://dx.doi.org/10.1093/jnci/djac067 |
Ejemplares similares
-
Utile or futile: biomarkers in the ICU
por: Balmelli, Cathrin, et al.
Publicado: (2011) -
Novel biomarkers in critical care: utility or futility?
por: Ackland, Gareth L, et al.
Publicado: (2007) -
Is prolonged mechanical ventilation of cancer patients futile?
por: Toffart, Anne-Claire, et al.
Publicado: (2013) -
The Futility of Flogging
Publicado: (1921) -
Resistance is futile
por: Semler, Bert L
Publicado: (2005)